Jiangsu Bioperfectus Technologies Co Ltd (688399) — Capital Reinvestment Ratio
Jiangsu Bioperfectus Technologies Co Ltd (688399) has a Capital Reinvestment Ratio of 1.00x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥20.00 Million) in capital expenditures (CN¥20.05 Million). See Jiangsu Bioperfectus Technologies Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Bioperfectus Technologies Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Jiangsu Bioperfectus Technologies Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Check cash flow reinvestment rate of Jiangsu Bioperfectus Technologies Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see market cap of Jiangsu Bioperfectus Technologies Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.43x | CN¥145.93 Million | CN¥62.86 Million | ▲ +141.3% |
| 2022 | 0.18x | CN¥1.96 Billion | CN¥350.74 Million | ▼ -42.1% |
| 2021 | 0.31x | CN¥985.52 Million | CN¥303.62 Million | ▲ +114.3% |
| 2020 | 0.14x | CN¥935.88 Million | CN¥134.56 Million | ▼ -85.5% |
| 2019 | 0.99x | CN¥106.72 Million | CN¥105.77 Million | ▼ -13.9% |
| 2018 | 1.15x | CN¥85.82 Million | CN¥98.74 Million | ▲ +141.8% |
| 2017 | 0.48x | CN¥61.59 Million | CN¥29.31 Million | ▼ -53.0% |
| 2016 | 1.01x | CN¥22.09 Million | CN¥22.37 Million | — |